About the role
ICON is a global healthcare intelligence and clinical research organisation united by a mission to bring new medicines and treatments to patients faster.
As a values-driven organisation, integrity, collaboration, agility, and inclusion are at the heart of how we work and interact with each other, customers, patients and suppliers.
Job title - Study Start Up Manager
Location - UK (remote)
Fully sponsor dedicated
Working fully embedded within a growing program via ICON, you will take ownership of end-to-end study start-up activities, ensuring timelines, quality standards, and regulatory requirements are met. Working at the heart of cross-functional teams, you’ll be instrumental in bringing innovative studies to life efficiently and compliantly.
What you’ll be responsible for:
Leading the study start-up strategy and execution for assigned trials
Managing site activation timelines, milestones, and deliverables
Partnering with regulatory, clinical, and external stakeholders to ensure smooth start-up processes
Overseeing site selection, feasibility, and activation activities
Identifying risks and proactively implementing solutions to keep studies on track
Ensuring compliance with all local and global regulatory requirements
What we’re looking for:
Solid experience in clinical operations and study start-up within a CRO or pharma environment
Full right to work in the UK
Strong project management skills with the ability to manage multiple priorities
Excellent stakeholder management and communication skills
A proactive, solution-focused mindset with high attention to detail
Ability to thrive in a fast-paced, global environment
Employment with ICON is contingent upon having the legal right to work in the country where the role is based.
Rewards & Benefits
ICON offers a competitive and comprehensive total rewards package designed to support your health, wellbeing, and career development.
Benefits may include:
- Competitive base salary and performance related incentives
- Health and wellbeing programmes including medical, dental, and vision coverage where applicable
- Retirement and pension plans
- Life assurance and disability coverage
- Employee assistance programmes and wellbeing resources
- Learning and development opportunities through structured training and career pathways
Benefits may vary depending on role and location.
Visit our careers site to read more about the benefits ICON offers.
Inclusion and Accessibility
ICON is an equal opportunity employer. We are committed to building an inclusive and accessible workplace where everyone feels valued and supported.
If you require reasonable accommodations during the recruitment process, please let us know or submit a request here.
Are you a current ICON Employee? Please click here to apply
Aplyr's read
ICON plc is a leading global provider of outsourced services in the pharmaceutical industry, attracting professionals in clinical research and data management.
What's promising
- •ICON plc has a strong global presence, enhancing its ability to manage international clinical trials effectively.
- •The company offers diverse career opportunities across various roles in clinical research and data analysis.
- •ICON's focus on innovation in pharmaceutical services supports its competitive edge in the industry.
What to watch
- •The pharmaceutical industry is highly regulated, which may limit flexibility in project execution.
- •ICON's reliance on large pharmaceutical clients could pose risks if partnerships dissolve.
- •The competitive nature of the CRO market may pressure ICON to maintain cost efficiency.
Why ICON plc
- •ICON plc specializes in comprehensive outsourcing solutions, differentiating it from competitors with narrower service scopes.
- •The company's integration of technology in clinical trials offers a unique advantage in data management.
- •ICON's strategic acquisitions have expanded its capabilities and market reach significantly.
Aplyr’s read is generated by AI from public sources. Was it useful?
About ICON plc
ICON plc is a global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology, and medical device industries.
